Literature DB >> 23916652

Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.

Masato Kanazawa1, Mari Tada, Osamu Onodera, Hitoshi Takahashi, Masatoyo Nishizawa, Takayoshi Shimohata.   

Abstract

BACKGROUND: Patients who develop progressive supranuclear palsy with predominant cerebellar ataxia (PSP-C) develop cerebellar ataxia as the initial and principal symptom, may be misdiagnosed as having multiple system atrophy with predominant cerebellar features (MSA-C). Therefore, we investigated the clinical signs and symptoms between PSP-C and MSA-C early in their disease course.
METHODS: We reviewed the medical records of 15 consecutive patients with pathologically proven PSP-C (4) and MSA-C (11). We recorded the presence or absence of clinical features that developed within 2 years of disease onset.
RESULTS: The age at onset of PSP-C patients was older than that of MSA-C patients (p = 0.009). The frequencies of falls were higher in PSP-C patients than in MSA-C patients (p = 0.026). Additionally, the development of supranuclear vertical gaze palsy was higher in PSP-C patients than in MSA-C patients (p = 0.011), whereas the frequency of dysautonomia was lower in PSP-C patients than in MSA-C patients (p = 0.035).
CONCLUSIONS: Older onset, early falls, and supranuclear vertical gaze palsy without dysautonomia may predict the diagnosis of PSP-C in patients with late-onset sporadic cerebellar ataxia.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cerebellar ataxia; Falls; MSA-C; Multiple system atrophy; NINDS-SPSP; National Institute for Neurological Diseases and Stroke – the Society for Progressive Supranuclear Palsy; PSP; PSP-C; Progressive supranuclear palsy; Supranuclear vertical gaze palsy; multiple system atrophy with predominant cerebellar features; progressive supranuclear palsy; progressive supranuclear palsy with predominant cerebellar ataxia

Mesh:

Year:  2013        PMID: 23916652     DOI: 10.1016/j.parkreldis.2013.07.019

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  24 in total

1.  Cerebellar ataxia in progressive supranuclear palsy: a clinico-pathological case report.

Authors:  David Crosiers; Anne Sieben; Sarah Ceyssens; Paul M Parizel; Jonathan Baets
Journal:  Acta Neurol Belg       Date:  2021-03-05       Impact factor: 2.396

2.  An autopsy confirmed case of progressive supranuclear palsy with predominant cerebellar ataxia.

Authors:  Myung Jun Lee; Jeong Hee Lee; Baik-Kyun Kim; Jae-Hyeok Lee; Young Min Lee; Seong-Jang Kim; Jin-Hong Shin; Myung-Jun Shin; Jae Woo Ahn; Suk Sung; Kyung-Un Choi; Dae Soo Jung; Na-Yeon Jung; William W Seeley; Gi Yeong Huh; Eun-Joo Kim
Journal:  J Neurol       Date:  2016-10-19       Impact factor: 4.849

Review 3.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

4.  Progressive Supranuclear Palsy and Corticobasal Degeneration.

Authors:  David G Coughlin; Dennis W Dickson; Keith A Josephs; Irene Litvan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Clinical Features and Neuroimaging Findings of Neuropil Antibody-Positive Idiopathic Sporadic Ataxia of Unknown Etiology.

Authors:  Akira Takekoshi; Akio Kimura; Nobuaki Yoshikura; Isamu Yamakawa; Makoto Urushitani; Katsuya Nakamura; Kunihiro Yoshida; Takayoshi Shimohata
Journal:  Cerebellum       Date:  2022-09-03       Impact factor: 3.648

6.  Typical or atypical progressive supranuclear palsy: a comparative clinicopathologic study of three Chinese cases.

Authors:  Ming-Wei Zhu; Jia Liu; Thomas Arzberger; Lu-Ning Wang; Zhen-Fu Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

7.  Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C.

Authors:  Shunsuke Koga; Keith A Josephs; Kotaro Ogaki; Catherine Labbé; Ryan J Uitti; Neill Graff-Radford; Jay A van Gerpen; William P Cheshire; Naoya Aoki; Rosa Rademakers; Zbigniew K Wszolek; Owen A Ross; Dennis W Dickson
Journal:  Mov Disord       Date:  2016-02-03       Impact factor: 10.338

8.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Authors:  Günter U Höglinger; Gesine Respondek; Maria Stamelou; Carolin Kurz; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Christer Nilsson; Jennifer L Whitwell; Thomas Arzberger; Elisabet Englund; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Yaroslau Compta; Jean-Christophe Corvol; Carlo Colosimo; Dennis W Dickson; Richard Dodel; Leslie Ferguson; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw R Morris; Peter Nestor; Wolfgang H Oertel; Werner Poewe; Gil Rabinovici; James B Rowe; Gerard D Schellenberg; Klaus Seppi; Thilo van Eimeren; Gregor K Wenning; Adam L Boxer; Lawrence I Golbe; Irene Litvan
Journal:  Mov Disord       Date:  2017-05-03       Impact factor: 10.338

Review 9.  Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies.

Authors:  Maria Stamelou; Gesine Respondek; Nikolaos Giagkou; Jennifer L Whitwell; Gabor G Kovacs; Günter U Höglinger
Journal:  Nat Rev Neurol       Date:  2021-08-23       Impact factor: 42.937

10.  Phenotypic Variants of Patients with Progressive Supranuclear Palsy.

Authors:  Murat Gültekın
Journal:  Noro Psikiyatr Ars       Date:  2017-11-08       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.